» Articles » PMID: 12827272

Antisense-mediated Redirection of MRNA Splicing

Overview
Publisher Springer
Specialty Biology
Date 2003 Jun 27
PMID 12827272
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Antisense technology has been used to study basic biological processes, and to block these processes when they deleteriously lead to human disease. A separate, equally important application of antisense technology is to upregulate the gene expression lost in the diseased state by shifting alternative splicing of pre-messenger RNA. This strategy has commonly relied upon the use of antisense oligonucleotides; however, another approach is to use a plasmid construct to generate antisense RNA inside the cell. Antisense therapeutics based on expression vectors and viral vectors offers a gene therapy approach, whereas those based on oligonucleotides offers a more drug like approach.

Citing Articles

Structure/affinity studies in the bicyclo-DNA series: Synthesis and properties of oligonucleotides containing bc(en)-T and iso-tricyclo-T nucleosides.

Dugovic B, Wagner M, Leumann C Beilstein J Org Chem. 2014; 10:1840-7.

PMID: 25161745 PMC: 4142851. DOI: 10.3762/bjoc.10.194.


Repair of pre-mRNA splicing: prospects for a therapy for spinal muscular atrophy.

Nlend R, Meyer K, Schumperli D RNA Biol. 2010; 7(4):430-40.

PMID: 20523126 PMC: 3070909. DOI: 10.4161/rna.7.4.12206.


Restoration of full-length SMN promoted by adenoviral vectors expressing RNA antisense oligonucleotides embedded in U7 snRNAs.

Geib T, Hertel K PLoS One. 2009; 4(12):e8204.

PMID: 19997596 PMC: 2781471. DOI: 10.1371/journal.pone.0008204.


Genetic correction of splice site mutation in purified and enriched myoblasts isolated from mdx5cv mice.

Maguire K, Suzuki T, DiMatteo D, Parekh-Olmedo H, Kmiec E BMC Mol Biol. 2009; 10:15.

PMID: 19236710 PMC: 2654480. DOI: 10.1186/1471-2199-10-15.


Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Laufer S, Restle T Curr Pharm Des. 2008; 14(34):3637-55.

PMID: 19075740 PMC: 2778081. DOI: 10.2174/138161208786898806.